Language bias in randomised controlled trials published in English and German

Matthias Egger(University of Zurich), Gerd Antes(University of Freiburg), Tanja Zellweger-Zähner(University of Bern), Christoph Junker(Federal Statistical Office), Christian Lengeler(Swiss Tropical and Public Health Institute), Martin Schneider(Heidelberg University)

The Lancet

August 1, 1997

10.1016/s0140-6736(97)02419-7

Cited by 1,044

Related Papers

Comparative Efficacy and Acceptability of 21 Antidepressant Drugs for the Acute Treatment of Adults With Major Depressive Disorder: A Systematic Review and Network Meta-Analysis

|The Lancet|2018|3.5k

CINeMA: An approach for assessing confidence in the results of a network meta-analysis

|PLoS Medicine|2020|1.7k

Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial

|The Lancet Oncology|2016|738

Predatory journals: no definition, no defence

|Nature|2019|723

CINeMA: Software for semiautomated assessment of the confidence in the results of network meta‐analysis

|Campbell Systematic Reviews|2020|560